Compare GameStop Corp. (GME) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GameStop Corp. vs Novartis AG — how do they compare? GameStop Corp. trades at $25.99 (market cap $12.75B), while Novartis AG trades at $143.49 (market cap $268.57B). The key difference: Novartis AG is far larger — about 21.1× GameStop Corp.'s market cap, and Novartis AG pays a 3.31% dividend while GameStop Corp. pays none. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 61 Days and Novartis AG for 82 Days on average.
| GME | NVS | |
|---|---|---|
Market Cap | $12.75B | $268.57B |
Volume | 13,026,993 | 1,532,573 |
Sector | Consumer Cyclical | Health |
52-Week High | $26.53 | $168.62 |
52-Week Low | $17.87 | $121.80 |
Typical Hold Time | 61 Days | 82 Days |
Enterprise Value | $12.03B | $309.89B |
Dividend Yield | — | 3.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GME trades at $24.58, down 0.73% on the day, with a bullish technical signal from moving averages and strong insider buying. Revenue declined to $3.82B in 2025, but net income improved to $131.3M with a 25.16% net margin. Recent news highlights CEO Ryan Cohen's aggressive share purchases, fueling positive sentiment.
Outlook hinges on execution of the high-margin collectibles pivot and eBay acquisition potential. Risks include revenue volatility and competitive pressures. Analysts are cautious with 55.55% hold ratings, but insider confidence offers a bullish counter-narrative.
Novartis (NVS) trades at $143.28, up 1.77% on the day, with a neutral technical signal and mixed earnings history. The company reported strong 2025 revenue of $56.67B and a net income margin of 22.5%, supported by a recent $7.8B licensing deal with China's Abogen. However, recent clinical trial setbacks and an ongoing law firm investigation introduce uncertainty.
The outlook is balanced; solid profitability and a consensus price target of $146.00 suggest modest upside, but risks from pipeline failures and heightened M&A scrutiny warrant caution. Investor sentiment is mixed, with analysts predominantly holding a neutral stance amid evolving business developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
